Publications found:
36,694
Sort by:
Vaccine Markets in the World to 2022 - Market Size, Development, and Forecasts
US$ 21,149.00
... (8.8%) and China (8.0%). The industry report package Vaccine Markets in the World to 2022 - Market Size, Development, and Forecasts offers the most ... the vaccine market in the world to 2022 Track industry development and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...
January 2018
1368 pages
Insulin Markets in the World to 2022 - Market Size, Development, and Forecasts
US$ 21,149.00
... the current size of the insulin market in the world and in different countries? How is the insulin market divided into different product segments? ... the insulin market in the world to 2022 Track industry development and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...
January 2018
1368 pages
Pediatric Vaccines Market Analysis By Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate), By Application (Infectious Diseases, Cancer, Allergy), By Region, And Segment Forecasts, 2014 - 2025
US$ 5,950.00
... . Further key findings from the report suggest: The global pediatric vaccines market was estimated at USD 22.4 billion in 2016 and is expected to grow with ...
January 2018
130 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Neurofeedback System Market 2017 Forecast to 2022
US$ 4,880.00
... report focuses on the Neurofeedback System in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Sensing Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...
January 2018
115 pages
Drug-Eluting Stents: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million. The report provides separate comprehensive analytics for the US, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2017
184 pages
Pharmaceutical Contract Manufacturing: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms: Injectables, Solid Dosage Forms, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2017
346 pages
Human Growth Hormone Drugs: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million. The report provides separate comprehensive analytics for the US, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2017
158 pages
Top 1,000 Major Pharmaceutical Companies 2018
US$ 495.00
PDF version is dispatched within twenty-four hours after the purchase. SYNOPSIS The most comprehensive and accurate Directory of the largest 1,000 pharmaceutical companies worldwide SUMMARY API research into pharmaceutical companies and corporations
December 2017
550 pages
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2017
US$ 3,500.00
... Alpha L-Iduronidase (IDUA or EC 3.2.1.76) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
48 pages
Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) - Pipeline Review, H2 2017
US$ 2,000.00
... Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2017
30 pages
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2017
US$ 3,500.00
... Integrin Alpha 7 (ITGA7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
25 pages
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Pipeline Review, H2 2017
US$ 3,500.00
... Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
62 pages
Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H2 2017
US$ 3,500.00
... Muscarinic Acetylcholine Receptor M4 (CHRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2017
65 pages
